Version June 2024
| Good risk candidates |
| Young age |
| No comorbid conditions |
| No active infections |
| Lymphohematopoietic disease in remission or responsive to therapy |
| Good socioeconomic support system |
| HLA-matched donor |
| Low risk of post-transplantation relapse |
| High risk candidates |
| Older age |
| Comorbid conditions present |
| Refractory/relapsed disease (diagnosis-dependent) |
| Aggressive prior therapy |
| High risk/complex karyotype |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
